WOLVERINE ASSET MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$380,000
+272.5%
63,091
+652.9%
0.00%
+100.0%
Q4 2014$102,000
+72.9%
8,380
+39.7%
0.00%
+100.0%
Q3 2014$59,000
+78.8%
6,000
+168.1%
0.00%
Q2 2014$33,000
+135.7%
2,238
-1.5%
0.00%
Q1 2014$14,000
-93.0%
2,271
-93.6%
0.00%
-100.0%
Q4 2013$200,000
-57.7%
35,236
-53.2%
0.00%
-63.6%
Q3 2013$473,000
+44.2%
75,238
+100.6%
0.01%
+22.2%
Q2 2013$328,00037,5040.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders